At a special meeting of EU health ministers next month, the possibility of member states sharing vaccines to protect against the H1N1 virus will be considered

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.587, 2009-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fight Against H1N1 Influenza A Virus: Recent Insights Towards the Development of Druggable Compounds

By  

Current Medicinal Chemistry, Vol. 23, Iss. 18, 2016-06 ,pp. : 1802-1817

Bentham Science Publishers

Access to resources Recommend Favorite

Bifunctional siRNA Containing Immunostimulatory Motif Enhances Protection Against Pandemic H1N1 Virus Infection

By  

Current Gene Therapy, Vol. 15, Iss. 5, 2015-08 ,pp. : 492-502

Bentham Science Publishers

Access to resources Recommend Favorite

An influenza A H5N1 virus vaccine elicits a protective response, even without an adjuvant and against divergent H5N1 strains

By  

Inpharma, Vol. 1, Iss. 1582, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Pharma accused as countries offload H1N1 vaccines

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 595, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Synthesis of New Compounds Combining Adamantanamine and Monoterpene Fragments and their Antiviral Activity Against Influenza Virus A(H1N1)pdm09

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 6, 2013-07 ,pp. : 477-485

Bentham Science Publishers

Access to resources Recommend Favorite